Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026.

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close

+1.9%1-day move

₹25.50

prior close

—

base price

After-mkt

timing

5m10m15m30m1D2D3D4D5D7D15D1M2M3M

————+1.9+2.8+8.6+5.0+4.1+4.3-5.3-0.8-14.1-34.5

Up moveDown movePending

AI summary

Venmax Drugs and Pharmaceuticals Ltd has submitted a compliance certificate confirming that securities dematerialization requests received from Depository Participants during the quarter ended March 31, 2026 were properly processed by CIL Securities Limited, the company's Registrar and Share Transfer Agent. The certificate verifies that dematerialized securities were confirmed to depositories and properly listed on stock exchanges. This is a routine regulatory filing required under SEBI regulations to ensure proper handling of share dematerialization and rematerialization requests.

Likely market impact

This is a standard regulatory compliance filing with no direct impact on the company's financials or stock price. It confirms proper adherence to SEBI's depository-related regulations for the quarter.